Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents
- Conditions
- Intervention
- Interventions
- Dietary Supplement: Tea polyphenolsDietary Supplement: AOB-wOther: PlaceboOther: Acrylamide (Potato Chips)
- Registration Number
- NCT03118167
- Lead Sponsor
- Zhejiang University
- Brief Summary
A double-blind randomized controlled trial (RCT) was conducted in current human study. This study aims to investigate the intervention effect of AOB-w on the short-term exposure and toxicokinetics of acrylamide, a dietary hazardous substance generated during heat processing, in Chinese adolescents.
- Detailed Description
In the morning of test day, participants were served with a meal of potato chips, corresponding to a single oral dose of 12.6 μg/kg b.w. exposure to acrylamide, and an edible capsule, which contains 350 mg AOB-w or the placebo with the same dose. Urine were collected within 48 hours thereafter. The diet was rigorously controlled within 24 hours prior to study till entire study finished. Four mercapturic acid metabolites have been investigated as urinary biomarkers for short-term internal exposure of acrylamide in human
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
- Subject has no smoking or drinking hobby
- Having any drugs within 7days
- Smoking or drinking
- Pregnant, trying to become pregnant or breast feeding
- Allergic frying foods
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo & Acrylamide Acrylamide (Potato Chips) Placebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose AOB-w & Acrylamide Acrylamide (Potato Chips) AOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose Tea polyphenols & Acrylamide Tea polyphenols TP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose AOB-w & Acrylamide AOB-w AOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose Placebo & Acrylamide Placebo Placebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose Tea polyphenols & Acrylamide Acrylamide (Potato Chips) TP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
- Primary Outcome Measures
Name Time Method Change of two hemoglobin adducts of acrylamide baseline, 3 and 10 days Blood samples were collected in 0, 3, 10days after the intake of potato chips meals. Two hemoglobin adducts (AAVal and GAVal) of acrylamide were detected by UHPLC-MS/MS.
Change of four urinary biomarkers of acrylamide up to 48 hours Urine was collected prior to the potato chips meal and 48 hours thereafter, up to 10 urine samples for each participants. Urinary biomarkers of acrylamide were detected by UHPLC-MS/MS.
- Secondary Outcome Measures
Name Time Method Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers 48 hours Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers during the specified period, measured by curve fitting tools of Matlab Software.
Area under the concentration versus time curve (AUC) Of acrylamide urinary biomarkers baseline, 2, 4, 6, 8, 10, 14, 24, 36 and 48 hours Dynamic changes of biomarkers during the specified intervention period, following 10 urine samples in 48 hours thereafter.
Maximum Concentration (Cmax) of Acrylamide Urinary Biomarkers 48 hours Maximum concentration of urinary biomarkers during the specified period, measured by curve fitting tools of Matlab Software.